These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 31485845)

  • 1. Serum amyloid A as a biomarker in differentiating attacks of familial Mediterranean fever from acute febrile infections.
    Çakan M; Aktay Ayaz N; Keskindemirci G; Karadağ ŞG; Tanatar A; Sönmez HE
    Clin Rheumatol; 2020 Jan; 39(1):249-253. PubMed ID: 31485845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Value of Serum Amyloid A Levels in Familial Mediterranean Fever to Identify Occult Inflammation During Asymptomatic Periods.
    Çakan M; Karadağ ŞG; Tanatar A; Sönmez HE; Ayaz NA
    J Clin Rheumatol; 2021 Jan; 27(1):1-4. PubMed ID: 31524848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of A-SAA in monitoring subclinical inflammation and in colchicine dosage in familial Mediterranean fever.
    Duzova A; Bakkaloglu A; Besbas N; Topaloglu R; Ozen S; Ozaltin F; Bassoy Y; Yilmaz E
    Clin Exp Rheumatol; 2003; 21(4):509-14. PubMed ID: 12942707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The value of the levels of acute phase reactants for the prediction of familial Mediterranean fever associated amyloidosis: a case control study.
    Yalçinkaya F; Cakar N; Acar B; Tutar E; Güriz H; Elhan AH; Oztürk S; Kansu A; Ince E; Atalay S; Girgin N; Doğru U; Aysev D; Ekim M
    Rheumatol Int; 2007 Apr; 27(6):517-22. PubMed ID: 17103173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concordance between CRP and SAA in familial Mediterranean fever during attack-free period: A study of 218 patients.
    Stankovic Stojanovic K; Hentgen V; Fellahi S; Georgin-Lavialle S; Amselem S; Grateau G; Bastard JP; Steichen O
    Clin Biochem; 2017 Mar; 50(4-5):206-209. PubMed ID: 27838405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C-reactive protein is more suitable than Serum Amyloid A to monitor crises and attack-free periods in Systemic Auto-Inflammatory Diseases.
    Parentelli AS; Lopes AA; Fellahi S; Savey L; Bastard JP; Georgin-Lavialle S
    Eur J Intern Med; 2024 Sep; 127():91-96. PubMed ID: 38724309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic validity of colchicine in patients with Familial Mediterranean fever.
    Ozaltin F; Bilginer Y; Gülhan B; Bajin I; Erdogan O; Hayran M; Yılmaz E; Ozen S
    Clin Rheumatol; 2014 Jul; 33(7):969-74. PubMed ID: 24740462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of S100A12 protein levels in children with familial Mediterranean fever.
    Türkmenoğlu Y; Güney E; Bezen D; İrdem A; Ertürk B; Dursun H
    Turk J Med Sci; 2021 Jun; 51(3):1396-1405. PubMed ID: 33576586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased circulating endothelial microparticles in children with FMF.
    Yel S; Dursun İ; Çetin F; Baştuğ F; Tülpar S; Düşünsel R; Gündüz Z; Poyrazoğlu H; Yılmaz K
    Biomarkers; 2018 Sep; 23(6):558-562. PubMed ID: 29611726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of serum calprotectin in identifying familial Mediterranean fever attacks.
    Polat MG; Omma A; Gokcen N; Kilinckaya MF; Ozkan Karaahmetoglu S
    Ir J Med Sci; 2024 Aug; 193(4):1901-1909. PubMed ID: 38478181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neutrophil-derived S100A12 as novel biomarker of inflammation in familial Mediterranean fever.
    Kallinich T; Wittkowski H; Keitzer R; Roth J; Foell D
    Ann Rheum Dis; 2010 Apr; 69(4):677-82. PubMed ID: 19762364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. S1000A12, Chitotriosidase, and Resolvin D1 as Potential Biomarkers of Familial Mediterranean Fever.
    Taylan A; Gurler O; Toprak B; Sisman AR; Yalcin H; Colak A; Sari I
    J Korean Med Sci; 2015 Sep; 30(9):1241-5. PubMed ID: 26339162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigation of the Levels of Serum Amyloid A, YKL-40, and Pentraxin-3 in Patients with Familial Mediterranean Fever.
    Ciftci S; Celik HT; Atukeren P; Ciftci N; Deniz MS; Coskun Yavuz Y; Hacievliyagil Kazanci F; Gök S; Demirin H; Yigitoglu MR
    J Clin Lab Anal; 2016 Nov; 30(6):1158-1163. PubMed ID: 27230955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of intima media thickness of the common and internal carotid arteries with inflammatory markers in familial Mediterranean fever as possible predictors for atherosclerosis.
    Bilginer Y; Ozaltin F; Basaran C; Duzova A; Besbas N; Topaloglu R; Ozen S; Bakkaloglu A
    Rheumatol Int; 2008 Oct; 28(12):1211-6. PubMed ID: 18500463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of serum CXC chemokine ligand 16 (CXCL16) as a novel inflammatory bio- marker or familial Mediterranean fever disease.
    Akyol T; Düzenli T; Tanoğlu A
    Turk J Med Sci; 2021 Apr; 51(2):813-818. PubMed ID: 33306334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of interferon alpha administration on acute attacks of familial Mediterranean fever: A double-blind, placebo-controlled trial.
    Tunca M; Akar S; Soytürk M; Kirkali G; Resmi H; Akhunlar H; Gönen O; Gallimore JR; Hawkins PN; Tankurt E
    Clin Exp Rheumatol; 2004; 22(4 Suppl 34):S37-40. PubMed ID: 15515782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specific glycosylation of alpha(1)-acid glycoprotein characterises patients with familial Mediterranean fever and obligatory carriers of MEFV.
    Poland DC; Drenth JP; Rabinovitz E; Livneh A; Bijzet J; van het Hof B; van Dijk W
    Ann Rheum Dis; 2001 Aug; 60(8):777-80. PubMed ID: 11454642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A single testing of serum amyloid a levels as a tool for diagnosis and treatment dilemmas in familial Mediterranean fever.
    Berkun Y; Padeh S; Reichman B; Zaks N; Rabinovich E; Lidar M; Shainberg B; Livneh A
    Semin Arthritis Rheum; 2007 Dec; 37(3):182-8. PubMed ID: 17512038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of pentraxin-3 in familial Mediterranean fever patients during attack and attack-free periods.
    Gok M; Sirkeci O; Kara M; Sakin YS; Tanoglu A; Sirkeci EE; Oztin H; Duzenli T; Kaplan M; Yazgan Y; Ipcioglu OM
    Bratisl Lek Listy; 2018; 119(8):490-493. PubMed ID: 30160156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is there a relationship between serum omentin level and acute phase response in patients with familial Mediterranean fever?
    Can Sandikci S; Omma A; Yucel C; Omma T
    Clin Rheumatol; 2021 Feb; 40(2):669-674. PubMed ID: 32623649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.